Alfimed AB is a Swedish AB based in Helsingborg, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2015, the company has 1 employee and reported revenue of SEK 5.5m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva import, marknadsföring och försäljning av ortopediska rehabiliteringsprodukter, äga och förvalta fast lös egendom samt därmed förenlig verksamhet.
In its most recent annual report (2025), Alfimed AB reported revenue of SEK 5.5m, broadly in line with the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of SEK 303.6k, and the EBITDA margin stood at 5.7%.
At the end of 2025, equity financed 48.6% of the balance sheet, and current assets covered short-term debt 1.9 times.
Frequently asked questions
What is the Org number of Alfimed AB?
Alfimed AB is registered with Bolagsverket / SCB under Org 5590021035.
What is the revenue of Alfimed AB?
Alfimed AB reported revenue of SEK 5.5m in 2025.
How many employees does Alfimed AB have?
Alfimed AB employs 1 people as of the latest annual report.
Who is the CEO of Alfimed AB?
Erik Mikael Eriksson is the CEO of Alfimed AB, in role since 2022.
Who is the chairman of Alfimed AB?
Jens Peter Allard chairs the board of Alfimed AB, in role since 2022.
Where is Alfimed AB headquartered?
Alfimed AB's registered address is Karbingatan 38.
